Michael Barbella, Managing Editor08.22.23
Spectral MD Holdings Ltd. is touting results from its 2018 Proof of Concept Study, published in the Journal of Burn Care & Research.
The study, titled "Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment," indicates that Spectral MD’s DeepView technology could help diagnose burn wounds earlier, including indeterminate burns.
"I am delighted the positive results from our first clinical study evaluating DeepView for burn wound healing assessment have been published. We believe that the need for fast, accurate, and binary burn wound assessment technology represents a critical unmet medical need," Spectral MD CEO Wensheng Fan said. "Currently, the incorrect judgement of burn depth remains common among even experienced surgeons. Moreover, specialized burn training for new doctors is becoming less common as it is no longer required during medical residency. The results of this study underlined the feasibility of DeepView for detecting healing and non-healing burn tissue, and subsequent studies have continued to demonstrate its reliability and increasing accuracy compared to the current standard of care."
Interim results from the company’s Burn Training Study, completed in March 2023, have continued to demonstrate the efficacy of the DeepView AI – Burns algorithm, which currently stands at 92% accuracy in determining healing vs. nonhealing tissue in burn wounds.
Spectral MD is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. The company’s DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results that have a goal of substantially exceeding the current standard of care in the future, Spectral MD’s diagnostic platform is expected to provide faster and more accurate treatment insight and improve patient care while reducing healthcare costs.
Study: JE Thatcher et al., Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment, Journal of Burn Care & Research, 2023;, irad051, https://doi.org/10.1093/jbcr/irad051
The study, titled "Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment," indicates that Spectral MD’s DeepView technology could help diagnose burn wounds earlier, including indeterminate burns.
"I am delighted the positive results from our first clinical study evaluating DeepView for burn wound healing assessment have been published. We believe that the need for fast, accurate, and binary burn wound assessment technology represents a critical unmet medical need," Spectral MD CEO Wensheng Fan said. "Currently, the incorrect judgement of burn depth remains common among even experienced surgeons. Moreover, specialized burn training for new doctors is becoming less common as it is no longer required during medical residency. The results of this study underlined the feasibility of DeepView for detecting healing and non-healing burn tissue, and subsequent studies have continued to demonstrate its reliability and increasing accuracy compared to the current standard of care."
Interim results from the company’s Burn Training Study, completed in March 2023, have continued to demonstrate the efficacy of the DeepView AI – Burns algorithm, which currently stands at 92% accuracy in determining healing vs. nonhealing tissue in burn wounds.
Spectral MD is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. The company’s DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results that have a goal of substantially exceeding the current standard of care in the future, Spectral MD’s diagnostic platform is expected to provide faster and more accurate treatment insight and improve patient care while reducing healthcare costs.
Study: JE Thatcher et al., Clinical Investigation of a Rapid Non-invasive Multispectral Imaging Device Utilizing an Artificial Intelligence Algorithm for Improved Burn Assessment, Journal of Burn Care & Research, 2023;, irad051, https://doi.org/10.1093/jbcr/irad051